Machielse Bernardus N M

CIK 00013150382 companiesPRINCETON, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001315038

Recent Transactions

19 trades

Disposition to Issuer
Omthera Pharmaceuticals, Inc.
Common Stock
2013-07-18−247,005→ 0 total
Exercise/Conversion
Omthera Pharmaceuticals, Inc.
Common Stock
2013-07-16$2.08/sh+221,404→ 247,005 total
Exercise/Conversion
Omthera Pharmaceuticals, Inc.
Stock Option (right to buy)
2013-07-16−221,404→ 0 total
Conversion
Omthera Pharmaceuticals, Inc.
Series B Convertible Preferred Stock
2013-04-16−35,722→ 0 total
Conversion
Omthera Pharmaceuticals, Inc.
Common Stock
2013-04-16+25,601→ 25,601 total
Disposition to Issuer
MEDIMMUNE INC /DE
Stock Option (right to buy)
2007-06-18−30,000→ 0 total
Disposition to Issuer
MEDIMMUNE INC /DE
Stock Option (right to buy)
2007-06-18−75,000→ 0 total
Disposition to Issuer
MEDIMMUNE INC /DE
Stock Option (right to buy)
2007-06-18−65,000→ 0 total
Disposition to Issuer
MEDIMMUNE INC /DE
Stock Option (right to buy)
2007-06-18−15,000→ 0 total
Disposition to Issuer
MEDIMMUNE INC /DE
Stock Option (right to buy)
2007-06-18−22,500→ 0 total
Disposition to Issuer
MEDIMMUNE INC /DE
Stock Option (right to buy)
2007-06-18−24,000→ 0 total
Disposition to Issuer
MEDIMMUNE INC /DE
Stock Option (right to buy)
2007-06-18−50,000→ 0 total
Disposition to Issuer
MEDIMMUNE INC /DE
Stock Option (right to buy)
2007-06-18−20,000→ 0 total
Disposition to Issuer
MEDIMMUNE INC /DE
Stock Option (right to buy)
2007-06-18−70,000→ 0 total
Disposition from Tender
MEDIMMUNE INC /DE
Common Stock
2007-06-01$58.00/sh−3,879→ 0 total
Award
MEDIMMUNE INC /DE
Stock Options (right to buy)
2007-02-15+65,000→ 65,000 total
Award
MEDIMMUNE INC /DE
Stock Options (Right to buy)
2006-11-08+20,000→ 20,000 total
Award
MEDIMMUNE INC /DE
Stock Options (Right to buy)
2005-02-16+75,000→ 75,000 total
Award
MEDIMMUNE INC /DE
Stock Options (Right to buy)
2005-01-27+20,000→ 20,000 total

Companies

Recent Filings

Address

C/O OMTHERA PHARMACEUTICALS, INC. 707 STATE ROAD

PRINCETON, NJ, 08540

View on SEC.gov